These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35220356)

  • 1. Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials.
    McManus KR; Lapid MI; Forester BP; Mueller M; Hermida AP; Nykamp L; Harper DG; Seiner SJ; Sanghani S; Patrick R; Gentry MT; Kung S; Leal JC; Johnson EK; Petrides G
    J ECT; 2022 Sep; 38(3):165-170. PubMed ID: 35220356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) - a promising option.
    Glass OM; Forester BP; Hermida AP
    Int Psychogeriatr; 2017 May; 29(5):717-726. PubMed ID: 28095946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol.
    Lapid MI; Merrill J; Mueller M; Hermida AP; Nykamp L; Andrus J; Azizi H; Bolton P; Bonsu N; Braga R; Dillon CR; Ecklesdafer D; Evans D; Harper D; Heintz H; Hussain-Krauter S; Holzgen O; Humphrey D; Jiwani S; Johnson EK; Kang S; Kassien J; Kim J; Knapp RG; Kung S; Kremen N; Le K; Mahdasian J; Marzouk T; Masrud JD; Mattingly J; Miller D; Pagali SR; Patrick R; Riva Posse P; Pritchett C; Rahman A; Rath S; Roczniak C; Rummans TA; Sanghani S; Seiner S; Smart L; Tomaschek E; Tsygankova V; VanderSchuur-White L; Walton MP; Wilkins J; Williams A; Williams SM; Petrides G; Forester BP
    PLoS One; 2024; 19(6):e0303894. PubMed ID: 38941338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of electroconvulsive therapy for the treatment of agitation and aggression in patients with dementia.
    Ujkaj M; Davidoff DA; Seiner SJ; Ellison JM; Harper DG; Forester BP
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):61-72. PubMed ID: 22143072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.
    Acharya D; Harper DG; Achtyes ED; Seiner SJ; Mahdasian JA; Nykamp LJ; Adkison L; Van der Schuur White L; McClintock SM; Ujkaj M; Davidoff DA; Forester BP
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):265-73. PubMed ID: 24838521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of ECT for Behavioral and Psychological Symptoms of Dementia (BPSD): A Retrospective Chart Review.
    Hermida AP; Tang YL; Glass O; Janjua AU; McDonald WM
    Am J Geriatr Psychiatry; 2020 Feb; 28(2):157-163. PubMed ID: 31668364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Electroconvulsive Therapy in Dementia-Related Agitation: A Case Series.
    Burton MC; Koeller SL; Brekke FM; Afonya AT; Sutor B; Lapid MI
    J ECT; 2017 Dec; 33(4):286-289. PubMed ID: 28658012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive Therapy for Agitation and Aggression in Dementia: A Systematic Review.
    van den Berg JF; Kruithof HC; Kok RM; Verwijk E; Spaans HP
    Am J Geriatr Psychiatry; 2018 Apr; 26(4):419-434. PubMed ID: 29107460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Approach to Monitoring Cognitive Adverse Events for Interventional Studies Involving Advanced Dementia Patients: Insights From the Electroconvulsive Therapy for Agitation in Dementia Study.
    Park S; Forester BP; Lapid MI; Harper DG; Hermida AP; Inouye SK; McClintock SM; Nykamp L; Petrides G; Schmitt EM; Seiner SJ; Mueller M; Patrick RE
    J Geriatr Psychiatry Neurol; 2024 May; 37(3):234-241. PubMed ID: 37848185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of maintenance electroconvulsive therapy for sustaining resolution of severe aggression in a major neurocognitive disorder.
    Selvadurai MI; Waxman R; Ghaffar O; Fischler I
    BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29305363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive Therapy for Neuropsychiatric Symptoms due to Major Neurocognitive Disorder: A Prospective, Observational Study.
    Chan P; Waxman RE; Woo S; Docherty C; Rayani K; Fischler I; Ghaffar O; Elmi S
    J ECT; 2022 Jun; 38(2):81-87. PubMed ID: 35613007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of agitation and aggression in four demented patients using ECT.
    Grant JE; Mohan SN
    J ECT; 2001 Sep; 17(3):205-9. PubMed ID: 11528314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe agitation in severe early-onset Alzheimer's disease resolves with ECT.
    Aksay SS; Hausner L; Frölich L; Sartorius A
    Neuropsychiatr Dis Treat; 2014; 10():2147-51. PubMed ID: 25419138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol for a parallel-group, double-blinded, randomized, controlled, noninferiority trial: the effect and safety of hybrid electroconvulsive therapy (Hybrid-ECT) compared with routine electroconvulsive therapy in patients with depression.
    Rong H; Xu SX; Zeng J; Yang YJ; Zhao J; Lai WT; Chen LC; Deng WF; Zhang X; Zhang YL; Li MZ; Xiao L; Xie XH
    BMC Psychiatry; 2019 Nov; 19(1):344. PubMed ID: 31694611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Effectiveness and Tolerability of Electroconvulsive Therapy in Patients with Neuropsychiatric Symptoms of Dementia.
    Isserles M; Daskalakis ZJ; Kumar S; Rajji TK; Blumberger DM
    J Alzheimers Dis; 2017; 57(1):45-51. PubMed ID: 28222513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series.
    Vishne T; Amiaz R; Grunhaus L
    J ECT; 2005 Jun; 21(2):118-21. PubMed ID: 15905755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.